Distinct in Vivo Engraftment and Growth Patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ Human Leukemia Cells in SCID Mice

Leukemia and Lymphoma

Volumn 32, Issue 42006, 1998, Pages 77-87

  Waurzyniak, Barabara J ^a,b,c,d,e   Heerema, Nyla ^a,b,c,d,e   Sensel, Martha G ^a,b,c,d,e   Gaynon, Paul S ^a,b,c,d,e   Kraft, Peter ^a,b,c,d,e   Sather, Harland N ^a,b,c,d,e   Chelstrom, Lisa ^a,b,c,d,e   Reaman, Gregory H ^a,b,c,d,e   Uckun, Fatih M ^a,b,c,d,e  

^a Children's Cancer Group ALL Biology Reference Laboratory   (United States)

^b CHILDREN S ONCOLOGY GROUP   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

growth pattern; human leukemia cells; in vivo engrafment; SCDI mice; t(1; 19) E2A PBX1; t(9; 22) BCR ABL

Indexed keywords

ABDOMINAL TUMOR; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW; BRAIN; CANCER GRAFT; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; FEMALE; HEART; HEPATOMEGALY; HUMAN; HUMAN CELL; KIDNEY; KIDNEY TUMOR; LIVER; LIVER TUMOR; LUNG; MALE; MESENTERY; MUSCLE; OVARY; PANCREAS; PRIORITY JOURNAL; SCID MOUSE; SKIN; SPLEEN; SPLENOMEGALY; THYMUS;

ADOLESCENT; ADULT; ANIMALS; CELL DIVISION; CHILD; CHILD, PRESCHOOL; FEMALE; FUSION PROTEINS, BCR-ABL; HOMEODOMAIN PROTEINS; HUMANS; INFANT; LEUKEMIA, EXPERIMENTAL; MALE; MICE; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; TRANSLOCATION, GENETIC;

EID: 0032467046     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428199809059248     Document Type: Article

References (43)

1. Pui C H, Raimondi S C, Hancock M L, Rivera G K, Ribeiro R C, Mahmoud H H, Sandlund J T, Crist W M, Behm F G. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23;p13) or its derivative. J Clin Oncol 1994; 12: 2601 – 6
2. Shikano T, Kaneko Y, Takazawa M, Ueno N, Ohkawa M, Fujimoto T. Balanced and Unbalanced 1:19 Translo-cation-Associated Acute Lymphoblastic Leukemias. Cancer 1986; 58: 2239 – 43
3. Crist W M, Carroll A J, Shuster J J, Behm F G, Whitehead M, Vietti T J, Look A T, Mahoney D, Ragab A, Pullen D J, et al. Poor Prognosis of Children With Pre-B Acute Lymphoblastic Leukemia Is Associated With the t(1;19)(q23;p13): a Pediatric Oncology Group Study. Blood 1990; 76: 117 – 22
4. Bloomfield C D, Seeker Walker L M, Goldman A I, Van Den Berghe H, De La Chapelle A, Ruutu T, Alimena G, Garson O M, Golomb H M, Rowley J D, et al. Six-Year Follow-Up of the Clinical Significance of Karyotype in Acute Lymphoblastic Leukemia. Cancer Gen Cytogen 1989; 40: 171 – 85
5. Raimondi S C. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993; 81: 2237 – 51
6. Clark S S, McLaughlin J, Crist W M, Champlin R, Witte O N. Unique forms of the abl tyrosine kinase distinguish Phi-positive CML from Phi-positive ALL. Science 1987; 235: 85 – 8
7. Hermans A, Heisterkamp N, Von Linden M, Van Baal S, Meijer D, Van Der Plas D, Wiedemann L M, Groffen J, Bootsma D, Grosveld G. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 1987; 51: 33 – 40
8. Hooberman A L, Carrino J J, Leibowitz D, Rowley J D, Le Beau M M, Arlin Z A, Westbrook C A. Unexpected Heterogeneity of Bcr-Abl Fusion Mrna Detected By Polymerase Chain Reaction in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Proc Natl Acad Sci USA 1989; 86: 4259 – 63
9. Canaani E, Gale R P, Steiner Saltz D, Berrebi A, Aghai E, Januszewicz E. Altered transcription of an oncogene in chronic myeloid leukaemia. Lancet 1984; 1: 593 – 5
10. Hunger S P, Galili N, Carroll A J, Crist W M, Link M P, Cleary M L. The t(1;19)(q23;p13) Results in Consistent Fusion of E2A and PBX1 Coding Sequences in Acute Lymphoblastic Leukemias. Blood 1991; 77: 687 – 93
11. Nourse J, Mellentin J D, Galili N, Wilkinson J, Stanbridge E, Smith S D, Cleary M L. Chromosomal Translocation t(1;19) Results in Synthesis of a Homeobox Fusion mRNA That Codes For a Potential Chimeric Transcription Factor. Cell 1990; 60: 535 – 45
12. Gaynon P S, Crotty M L, Sather H N, Bostrom B C, Nachman J B, Steinherz P G, Heerema N A, Sarquis M, Tuel Ahlgren L, Uckun F M. Expression of BCR-ABL, E2A-PBXI, and MLL-AF4 fusion transcripts in newly diagnosed children with acute lymphoblastic leukemia: a Children's Cancer Group initiative. Leuk Lymphoma 1997; 26: 57 – 65
13. Steinherz P G, Gaynon P, Miller D R, Reaman G, Bleyer A, Finklestein J, Evans R G, Meyers P, Steinherz L J, Sather H, et al. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen-a new intensive therapy protocol: a report from the Childrens Cancer Study Group. J Clin Oncol. 1986; 4: 744 – 52
14. Nachman J, Sather H, Cherlow J, Sensel M, Gaynon P, Lukens J, Wolff L, Trigg M. Response of children with high risk acute lymphoblastic leukemia treated with and without cranial irradiation: A Report from the Children's Cancer Group. J Clin Oncol 1998, in press
15. Nachman J, Sather H, Lukens J, Gaynon P, Wolff L, Cherlow J, Trigg M. Augmented Berlin-Frankfurt-Munster (A-BFM) chemotherapy improves event-free survival (EFS) for children with acute lymphoblastic leukemia and unfavorable presenting features who show a slow early response to induction therapy. Blood 1997; 90: 558a
16. Uckun F, Reaman G, Steinherz P, Arthur D, Sather H, Trigg M, Tubergen D, Gaynon P. Improved Outcome for Children with T-Lineage Acute Lymphoblastic Leukemia After Contemporary Chemotherapy: A Children's Cancer Group Study. Leuk Lymphoma 1996; 24: 57 – 70
17. Tubergen D, Gilchrist G, O'Brien A, Coccoa P, Sather H, Waskcrwitz M, Hammond D. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features. J Clin Oncol 1993; 11: 527 – 537
18. Uckun F M, Nachman J B, Sather H N, Sensel M G, Theil K, Kraft P, Steinherz P G, Lange B, et al. Clinical Significance of Philadelphia Chromosome-Positive Pediatric Acute Lymphoblastic Leukemia in the Context of Contemporary Intensive Therapies: A Report from the Children's Cancer Group. Cancer 1998, in press
19. Uckun F, Sensel M, Sather H, Gaynon P, Arthur D, Lange B, Steinherz P, Kraft P, Hutchinson R, Nachman J, et al. Clinical Significance of Translocation t(1;19) in Childhood Acute Lymphoblastic Leukemia: A Report from the Children's Cancer Group. J Clin Oncol 1998; 16: 527 – 535
20. Uckun F M, Manivel C, Arthur D, Chelstrom L M, Finnegan D, Tuel Ahlgren L, Irvin J D, Myers D E, Gunther R. In vivo efficacy of B43 (anti-CD 19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 1992; 79: 2201 – 14
21. J Kamel Reid S, Letarte M, Sirard C, Doedens M, Grunberger T, Fulop G, Freedman M H, Phillips R A, Dick J E. A Model of Human Acute Lymphoblastic Leukemia in Immune-Deficient SCID Mice. Science 1989; 246: 1597 – 600
22. Kamel Reid S, Letarte M, Doedens M, Greaves A, Murdoch B, Grunberger T, Lapidot T, Thomer P, Freedman M H, Phillips R A, et al. Bone Marrow From Children in Relapse With Pre-B Acute Lymphoblastic Leukemia Proliferates and Disseminates Rapidly in SCID Mice. Blood 1991; 78: 2973 – 81
23. McCune J M, Namikawa R, Kaneshima H, Shultz L D, Lie-Berman M, Weissman I L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988; 241: 1632 – 9
24. Mosier D E, Gulizia R J, Baird S M, Wilson D B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335: 256 – 9
25. Dick J E, Lapidot T, Pflumio F. Transplantation of normal and leukemic human bone marrow into immune-deficient mice: development of animal models for human hematopoiesis. Immunol Rev 1991; 124: 25 – 43
26. Uckun F M, Downing J R, Gunther R, Chelstrom L M, Finnegan D, Land V J, Borowitz M J, Carroll A J, Crist W M. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 1993; 81: 3052 – 62
27. Uckun F M, Downing J R, Chelstrom L M, Gunther R, Ryan M, Simon J, Carroll A J, Tuel Ahlgren L, Crist W M. Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 1994; 84: 859 – 65
28. Uckun F M, Sather H, Reaman G, Shuster J, Land V, Trigg M, Gunther R, Chelstrom L, Bleyer A, Gaynon P., et al. Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia. Blood 1995; 85: 873 – 8
29. Reaman G H, Sposto R, Sensel M G, Lange B J, Feusner J, Heerema N A, Leonard M, Holmes E, et al. Treatment Outcome and Prognostic Factors for infants with Acute Lymphoblastic Leukemia Treated on Consecutive trials of the Children's Cancer Group. JCO 1998, in press
30. Bostrom B, Gaynon P, Sather H, Gold S, Hutchinson R, Provisor A, Trigg M. Dexamethasone (DEX) decreases central nervous system (CNS) relapse in lower risk acute lymphoblastic leukemia (ALL). Proc Amer Sac Clin Oncol 1998, in press
31. J Uckun F, Ledbetter M. JA. Immunobiologic differences between normal and leukemic human B-cell precursors. Proc Natl Acad Sci USA 1988; 85: 8603 – 7
32. Uckun F M, Gajl Peczalska K J, Provisor A J, Heerema N A. Immunophenotypekaryotype associations in human acute lymphoblastic leukemia. Blood 1989; 73: 271 – 80
33. Heerema N A, Arthur D, Sather C. H, Albo V, Feusner J, Lange B J, Steinherz P G, Zeltzer P, Hammond D, Reaman G H. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group. Blood 1994; 83: 2274 – 84
34. Mitelman F. ISCN: An International System for Human Cytogenetic Nomenclature. Karger, Basel Switzwerland 1995
35. Gunther R, Chelstrom L M, Finnegan D, Tuel Ahlgren L, Irvin J D, Myers D E, Uckun F M. In vivo anti-leuke-mic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiency. Leukemia 1993; 7: 298 – 309
36. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163 – 170
37. Peto R, Pike M C, Armitage P, Breslow N, Cox D R, Howard S V, Mantel N, McPherson K, Peto J, Smith P G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II. Analysis and examples. Br J Cancer 1977; 35: 1 – 39
38. Breslow N. Analysis of survival data under the proportional hazards model. Int Stat Rev 1975; 43: 45 – 58
39. Sirard C, Lapidot T, Vormoor J, Cashman J, Doedens M, Murdoch B, Jamal N, Messner H, Addey L, Minden M, et al. Normal and Leukemic SCID-Reproducing Cells (SRC) Coexist in the Bone Marrow and Peripheral Blood from CML Patients in Chronic Phase, Whereas Leukemic SRC are Detected in Blast Crisis. Blood 1996; 84: 1539 – 1548
40. Lewis I, McDiarmid L, Samels L, To L, Hughes T. Establishment of a Reproducible Model of Chronic-Phase Chronic Myeloid Leukemia in NOD/SCID Mice Using Blood-Derived Mononuclear or CD34+ Cells. Blood 1998; 91: 630 – 640
41. Uckun F M, Stewart C F, Reaman G, Chelstrom L M, Jin J, Chandan Langlie M, Waddick K G, White J, Evans W E. In vitro and in vivo activity of topotecan against human B-lineage acute lymphoblastic leukemia cells. Blood 1995; 85: 2817 – 28
42. Waurzyniak B, Schneider E A, Turner N, Yanishevski Y, Gunther R, Chelstrom L M, Wendorf H, Myers D E, Irvin J D, Messinger Y, et al. In Vivo Toxicity, Pharmacokinetics, and Antileukemic Activity of TXU (Anti-CD7)-Pokeweed Antiviral Protein Immunotoxin. Clin Cancer Res 1997; 3: 881 – 890
43. Waddick K G, Myers D E, Gunther R, Chelstrom L M, Chan-Dan Langlie M, Irvin J D, Turner N, Uckun F M. In vitro and in vivo antileukemic activity of B43-pokeweed antiviral protein against radiation-resistant human B-cell precursor leukemia cells. Blood 1995; 86: 4228 – 33